Efficacy of Indobufen in the Treatment of Intermittent Claudication
- 1 August 1988
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 39 (8) , 742-746
- https://doi.org/10.1177/000331978803900806
Abstract
The aim of this trial was to assess the activity of indobufen compared with placebo in peripheral occlusive arterial disease of the lower limbs of atheroscle rotic or diabetic origin. Fifty-two outpatients were admitted to the randomized, double-blind study and were given either an indobufen 200-mg tablet (28 sub jects) or placebo (24) for six months.This publication has 7 references indexed in Scilit:
- Inhibition of platelet function with indobufen: Correlation with plasma drug levelThrombosis Research, 1985
- MICROTHROMBUS FORMATION ON HEMODIALYSIS MEMBRANES - A PLACEBO CONTROLLED RANDOMIZED TRAIL OF 2 DOSES OF INDOBUFEN1985
- The Incidence of Deep Venous Thrombosis in Patients with an Acute Myocardial Infarction Treated with Acenocoumarol or IndobufenThrombosis and Haemostasis, 1982
- Indobufen treatment in type iia hypercholesterolemic subjects: Effects on platelet function and malondialdehyde productionPharmacological Research Communications, 1981
- PRELIMINARY HUMAN PHARMACOLOGY STUDIES ON THE INHIBITION OF PLATELET-AGGREGATION BY INDOBUFEN (K-3920)1981
- Clinical Pharmacology Studies with Indobufen (K 3920): Inhibitor of Platelet AggregationThe Journal of Clinical Pharmacology, 1980